Table 1

Pathoclinical details of tamoxifen-sensitive and -resistant breast tumors

GroupMean age (range) (yr)HistologyLymph nodeUICC gradeaER-α
DuctalLobular+123+
Tamoxifen-sensitive group (n = 8)66 (53–80)803523353
Tamoxifen-resistant group (n = 9)64 (49–78)726322581
  • a UICC, Union International Contre le Cancer.